We studied treatment patterns for adrenal metastases using surgery or SABR at a single institution during a 10-year period. The number of patients undergoing SABR doubled since 2016, without a change in numbers undergoing surgery. Both treatments resulted in low rates of acute toxicity and similar survivals.
Original languageEnglish
Pages (from-to)165-168
Number of pages4
JournalRadiotherapy and Oncology
Early online date24 Feb 2022
Publication statusPublished - May 2022

Cite this